Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

54.9%
Female
45.1%
Male

Age Information

The average age of patients reporting adverse events with ROSUVASTATIN is 66.1 years.

Geographic Distribution

The majority of adverse event reports for ROSUVASTATIN originate from US.

Report Summary & Outcomes

36,332
Total Reports
36,332
As Primary/Secondary Suspect
1,536
Deaths Reported
11,195
Hospitalizations
1,865
Life-Threatening
1,920
Disabilities

Reporting Timeline

First adverse event report: 19481121. Most recent report: 20250926. View full timeline →

More About ROSUVASTATIN

ROSUVASTATIN Full Profile Reports by Year Drug Interactions